As of the most recent data, NVS shows a P/E ratio of 20.83. That is below the Healthcare sector average of 24.78. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 24.78. Novartis AG is at 20.83, which is lower that average. That is roughly 15.9% below the sector mean. Use the comparison chart on this page to see how NVS stacks up against individual peers as well.

Investors watch NVS's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Novartis AG's latest reading is 20.83. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 20.83) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 24.78, while NVS is at 20.83. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.